Clinical Trial

TelePharm PrEP/PEP

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. The investigators hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-12
Trial Details
NCT Number NCT07561658
Lead Sponsor Fred Hutchinson Cancer Center
Collaborators: Kenya Medical Research Institute, ClickMedix LLC, National Institute of Mental Health (NIMH)
Conditions HIV
Enrollment 1,580 participants
Start Date 2026-10-01
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-11